Optimising diagnosis and management of kidney disease: an implementation trial of a clinical decision support system future health today
Loading...
Citations
Scopus:
Altmetric:
Altmetric::
Download
Associated Records
Authors
File Licence
Editors
Date
2024-02-16
Source Title
BMC Nephrology
Journal Title
Journal ISSN
Volume Title
Publisher
BMC
Melbourne Authors
Affiliation
General Practice and Primary Care
Medicine, Western Health
Centre for Digital Transformation of Health
Medicine, Western Health
Centre for Digital Transformation of Health
Document Type
Journal Article
Subject Code
Citation
Wallace, H., Wang, Q., Botha, T., Hunter, B., Lumsden, N. & Nelson, C. (2024). Optimising diagnosis and management of kidney disease: an implementation trial of a clinical decision support system future health today. BMC Nephrology, 25 (1), https://doi.org/10.1186/s12882-024-03489-y.
Access Status
Open Access
Access URL
Open Access URL
published version
Open Access at PMC
Linked Resource URL
NHMRC Grant Code
ARC Grant Code
Description
Abstract
BACKGROUND: Chronic kidney disease affects more than 10% of the world's population and is a non-communicable disease of global concern and priority. There is a significant implementation gap between best practice guideline recommendations and current kidney disease management. Previous research has shown the need to partner with primary care to improve education, collaboration, and kidney disease awareness. This implementation trial will explore use of an innovative clinical decision support software, Future Health Today, to improve screening, diagnosis, and management of kidney disease in primary care. The program will be supported by tertiary care outreach services. The primary aim is to test the hypothesis that the Future Health Today implementation program will improve screening, diagnosis, and management of kidney disease. Secondary aims are to evaluate primary care satisfaction and broader health service impacts. METHODS: This pre-post implementation trial using an interrupted time series design will evaluate the clinical and service outcomes of Future Health Today, using a mixed methods study in twenty general practices with an estimated population size of 150,000. Deidentified patient data will be extracted from participating practices to examine the primary aims of the study. Surveys and semi-structured interviews with general practice will inform secondary hypotheses. Data linkage between primary care and tertiary care data will examine the broader health service impacts. DISCUSSION: This investigator driven trial will assess the impact of Future Health Today software coupled with education and clinical outreach support. Investigators hypothesise that there will be improvement in appropriate screening, diagnosis, and management of kidney disease. This program has the potential to be scaled more broadly. TRIAL REGISTRATION: Australian New Zealand Clinical Trial Registry: ACTRN12623001096640.